메뉴 건너뛰기




Volumn 129, Issue 1, 2008, Pages 3-9

Cutaneous vasculitis in breast cancer treated with chemotherapy

Author keywords

Breast cancer; Case report; Vasculitis

Indexed keywords

ANASTROZOLE; ANTITHYROID AGENT; COLCHICINE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; FULVESTRANT; GABAPENTIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LETROZOLE; PROPYLTHIOURACIL; STEROID; TAMOXIFEN; THIAMAZOLE; TRASTUZUMAB;

EID: 51249087724     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.07.001     Document Type: Short Survey
Times cited : (36)

References (46)
  • 1
    • 0027319465 scopus 로고
    • Vasculitis and cancer
    • Kurzrock R., and Cohen P. Vasculitis and cancer. Clin. Dermatol. 11 1 (1993) 175-187
    • (1993) Clin. Dermatol. , vol.11 , Issue.1 , pp. 175-187
    • Kurzrock, R.1    Cohen, P.2
  • 2
    • 0028069683 scopus 로고
    • Clinical manifestations of vasculitis in patients with solid tumors
    • Kurzrock R., Cohen P., and Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors. Arch. Intern. Medical. 154 3 (1994) 334-340
    • (1994) Arch. Intern. Medical. , vol.154 , Issue.3 , pp. 334-340
    • Kurzrock, R.1    Cohen, P.2    Markowitz, A.3
  • 3
    • 1342287488 scopus 로고    scopus 로고
    • Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia
    • Cabuk M., et al. Cyclic lymphocytic vasculitis associated with chronic lymphocytic leukemia. Leuk. Lymphoma. 45 4 (2004) 811-813
    • (2004) Leuk. Lymphoma. , vol.45 , Issue.4 , pp. 811-813
    • Cabuk, M.1
  • 4
    • 0027384254 scopus 로고
    • The spectrum of cutaneous disease in leukemias
    • Desch J., and Smoller B. The spectrum of cutaneous disease in leukemias. J. Cutan. Pathol. 20 5 (1993) 407-410
    • (1993) J. Cutan. Pathol. , vol.20 , Issue.5 , pp. 407-410
    • Desch, J.1    Smoller, B.2
  • 5
    • 33644825973 scopus 로고    scopus 로고
    • Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis
    • Carlson J., Ng B., and Chen K. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am. J. Dermatopathol. 27 6 (2005) 504-528
    • (2005) Am. J. Dermatopathol. , vol.27 , Issue.6 , pp. 504-528
    • Carlson, J.1    Ng, B.2    Chen, K.3
  • 6
    • 0034091299 scopus 로고    scopus 로고
    • Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies
    • Choi H., et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis. Rheum. 43 2 (2000) 405-413
    • (2000) Arthritis. Rheum. , vol.43 , Issue.2 , pp. 405-413
    • Choi, H.1
  • 7
    • 0031006210 scopus 로고    scopus 로고
    • Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature
    • Kitahara T., et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin. Nephrol. 47 5 (1997) 336-340
    • (1997) Clin. Nephrol. , vol.47 , Issue.5 , pp. 336-340
    • Kitahara, T.1
  • 8
    • 40349116031 scopus 로고    scopus 로고
    • Drug-induced vasculitis
    • Wiik A. Drug-induced vasculitis. Curr. Opin. Rheumatol. 20 (2008) 35-39
    • (2008) Curr. Opin. Rheumatol. , vol.20 , pp. 35-39
    • Wiik, A.1
  • 9
    • 0036143936 scopus 로고    scopus 로고
    • Cutaneous and systemic manifestations of drug-induced vasculitis
    • ten Holder S., Joy M., and Falk R. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. 36 1 (2002) 130-147
    • (2002) Ann. Pharmacother. , vol.36 , Issue.1 , pp. 130-147
    • ten Holder, S.1    Joy, M.2    Falk, R.3
  • 10
    • 0036022549 scopus 로고    scopus 로고
    • Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus
    • Thong H., Chu C., and Chiu H. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta. Derm. Venereol. 82 3 (2002) 206-208
    • (2002) Acta. Derm. Venereol. , vol.82 , Issue.3 , pp. 206-208
    • Thong, H.1    Chu, C.2    Chiu, H.3
  • 11
    • 0036176961 scopus 로고    scopus 로고
    • Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism
    • Herlin T., et al. Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand. J. Rheumatol. 31 1 (2002) 46-49
    • (2002) Scand. J. Rheumatol. , vol.31 , Issue.1 , pp. 46-49
    • Herlin, T.1
  • 12
    • 0034527641 scopus 로고    scopus 로고
    • High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil
    • Sato H., et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 85 11 (2000) 4270-4273
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , Issue.11 , pp. 4270-4273
    • Sato, H.1
  • 13
    • 0024337144 scopus 로고
    • Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
    • Slamon D., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 4905 (1989) 707-712
    • (1989) Science , vol.244 , Issue.4905 , pp. 707-712
    • Slamon, D.1
  • 14
    • 0034871354 scopus 로고    scopus 로고
    • HER2 as a prognostic and predictive marker for breast cancer
    • Cooke T., et al. HER2 as a prognostic and predictive marker for breast cancer. Ann. Oncol. 12 Suppl 1 (2001) S23-28
    • (2001) Ann. Oncol. , vol.12 , Issue.SUPPL. 1
    • Cooke, T.1
  • 15
    • 4143112475 scopus 로고    scopus 로고
    • Pharmacological background of EGFR targeting
    • Castillo L., et al. Pharmacological background of EGFR targeting. Ann. Oncol. 15 7 (2004) 1007-1112
    • (2004) Ann. Oncol. , vol.15 , Issue.7 , pp. 1007-1112
    • Castillo, L.1
  • 16
    • 0034773992 scopus 로고    scopus 로고
    • The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities
    • Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer. 37 Suppl 4 (2001) S3-8
    • (2001) Eur. J. Cancer. , vol.37 , Issue.SUPPL. 4
    • Yarden, Y.1
  • 17
    • 40849147041 scopus 로고    scopus 로고
    • EGFR antagonists in cancer treatment
    • Ciardiello F., and Tortora G. EGFR antagonists in cancer treatment. N. Engl. J. Med. 358 11 (2008) 1160-1174
    • (2008) N. Engl. J. Med. , vol.358 , Issue.11 , pp. 1160-1174
    • Ciardiello, F.1    Tortora, G.2
  • 18
    • 0026583746 scopus 로고
    • Cyclin A is required at two points in the human cell cycle
    • Pagano M., et al. Cyclin A is required at two points in the human cell cycle. EMBO. J. 11 3 (1992) 961-971
    • (1992) EMBO. J. , vol.11 , Issue.3 , pp. 961-971
    • Pagano, M.1
  • 19
    • 0034864042 scopus 로고    scopus 로고
    • Chromatin assembly and organization
    • Ridgway P., and Almouzni G. Chromatin assembly and organization. J. Cell. Sci. 114 Pt 15 (2001) 2711-2712
    • (2001) J. Cell. Sci. , vol.114 , Issue.PART 15 , pp. 2711-2712
    • Ridgway, P.1    Almouzni, G.2
  • 20
    • 33747868707 scopus 로고    scopus 로고
    • Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway
    • Le X., et al. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell. Cycle. 5 15 (2006) 1654-1661
    • (2006) Cell. Cycle. , vol.5 , Issue.15 , pp. 1654-1661
    • Le, X.1
  • 21
    • 0034665757 scopus 로고    scopus 로고
    • NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
    • Zhao J., et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14 18 (2000) 2283-2297
    • (2000) Genes Dev. , vol.14 , Issue.18 , pp. 2283-2297
    • Zhao, J.1
  • 22
    • 8644219655 scopus 로고    scopus 로고
    • Living with or without cyclins and cyclin-dependent kinases
    • Sherr C., and Roberts J. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 22 (2004) 2699-2711
    • (2004) Genes Dev. , vol.18 , Issue.22 , pp. 2699-2711
    • Sherr, C.1    Roberts, J.2
  • 23
    • 33644635247 scopus 로고    scopus 로고
    • A review of EGFR targeted therapy
    • Baselga J. A review of EGFR targeted therapy. Clin. Adv. Hematol. Oncol. 1 14 (2003) 218-219
    • (2003) Clin. Adv. Hematol. Oncol. , vol.1 , Issue.14 , pp. 218-219
    • Baselga, J.1
  • 24
    • 0035724536 scopus 로고    scopus 로고
    • Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
    • Busam K., et al. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br. J. Dermatol. 144 6 (2001) 1169-1176
    • (2001) Br. J. Dermatol. , vol.144 , Issue.6 , pp. 1169-1176
    • Busam, K.1
  • 25
    • 0036051312 scopus 로고    scopus 로고
    • Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
    • Van Doorn R., et al. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br. J. Dermatol. 147 3 (2002) 598-601
    • (2002) Br. J. Dermatol. , vol.147 , Issue.3 , pp. 598-601
    • Van Doorn, R.1
  • 26
    • 26944467607 scopus 로고    scopus 로고
    • Management of EGFR-inhibiotr-related skin reactions
    • Segaert S., et al. Management of EGFR-inhibiotr-related skin reactions. J. Dtsch. Dermatol. Ges. 3 8 (2005) 599-606
    • (2005) J. Dtsch. Dermatol. Ges. , vol.3 , Issue.8 , pp. 599-606
    • Segaert, S.1
  • 27
    • 34548395965 scopus 로고    scopus 로고
    • Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib
    • Boeck S., Wollenberg A., and Heinemann V. Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib. Ann. Oncol. 18 9 (2007) 1582-1583
    • (2007) Ann. Oncol. , vol.18 , Issue.9 , pp. 1582-1583
    • Boeck, S.1    Wollenberg, A.2    Heinemann, V.3
  • 28
    • 33750584030 scopus 로고    scopus 로고
    • HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy
    • Wen X., et al. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene 2 25 (2006) 6986-6996
    • (2006) Oncogene , vol.2 , Issue.25 , pp. 6986-6996
    • Wen, X.1
  • 29
    • 0036139727 scopus 로고    scopus 로고
    • Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition
    • Albanell J., et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J. Clin. Oncol. 1 20 (2002)
    • (2002) J. Clin. Oncol. , vol.1 , Issue.20
    • Albanell, J.1
  • 30
    • 5044223956 scopus 로고    scopus 로고
    • A review of adjuvant hormonal therapy in breast cancer
    • Jones K., and Buzdar A. A review of adjuvant hormonal therapy in breast cancer. Endocrine-related Cancer 11 (2004) 392-406
    • (2004) Endocrine-related Cancer , vol.11 , pp. 392-406
    • Jones, K.1    Buzdar, A.2
  • 31
    • 33846971221 scopus 로고    scopus 로고
    • Tamoxifen-associated vasculitis in a breast cancer patient
    • (5)
    • Candelaria M., et al. Tamoxifen-associated vasculitis in a breast cancer patient. World. J. Surg. Oncol. 23 5 (2007) 9 (5)
    • (2007) World. J. Surg. Oncol. , vol.23 , Issue.5 , pp. 9
    • Candelaria, M.1
  • 32
    • 33846518466 scopus 로고    scopus 로고
    • Henoch-Schönlein purpura (HSP) during treatment with anastrozole
    • Conti-Beltraminelli M., et al. Henoch-Schönlein purpura (HSP) during treatment with anastrozole. Annals of Oncology 18 1 (2007) 205-207
    • (2007) Annals of Oncology , vol.18 , Issue.1 , pp. 205-207
    • Conti-Beltraminelli, M.1
  • 33
    • 0025321905 scopus 로고
    • Tamoxifen and purpuric vasculitis
    • Drago F., Arditi M., and Rebora A. Tamoxifen and purpuric vasculitis. Ann. Intern. Med. 112 12 (1990) 965-966
    • (1990) Ann. Intern. Med. , vol.112 , Issue.12 , pp. 965-966
    • Drago, F.1    Arditi, M.2    Rebora, A.3
  • 34
    • 16344387532 scopus 로고    scopus 로고
    • Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment
    • Shoda H., et al. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment. Ann. Rheum. Dis. 64 (2005) 651-652
    • (2005) Ann. Rheum. Dis. , vol.64 , pp. 651-652
    • Shoda, H.1
  • 35
    • 0022617357 scopus 로고
    • Cutaneous paraneoplastic syndromes
    • McLean D. Cutaneous paraneoplastic syndromes. Arch. Dermatol. 122 (1986) 765-767
    • (1986) Arch. Dermatol. , vol.122 , pp. 765-767
    • McLean, D.1
  • 36
    • 34848867563 scopus 로고    scopus 로고
    • Cutaneous vasculitis as a paraneoplastic syndrome in childhood
    • Pelajo C., et al. Cutaneous vasculitis as a paraneoplastic syndrome in childhood. Acta. Reumatol. Port. 32 2 (2007) 181-183
    • (2007) Acta. Reumatol. Port. , vol.32 , Issue.2 , pp. 181-183
    • Pelajo, C.1
  • 37
    • 0025243457 scopus 로고
    • Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.
    • Sánchez-Guerrero J., et al. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J. Rheumatol. 17 11 (1990) 1458-1462
    • (1990) J. Rheumatol. , vol.17 , Issue.11 , pp. 1458-1462
    • Sánchez-Guerrero, J.1
  • 38
    • 0023811560 scopus 로고
    • Vasculitis associated with malignancy. Experience with 13 patients and literature review.
    • Greer J., et al. Vasculitis associated with malignancy. Experience with 13 patients and literature review. Med. (Baltimore) 67 4 (1988) 220-230
    • (1988) Med. (Baltimore) , vol.67 , Issue.4 , pp. 220-230
    • Greer, J.1
  • 39
    • 0031415976 scopus 로고    scopus 로고
    • Systemic vasculitis and epithelioma
    • Hayem G., et al. Systemic vasculitis and epithelioma. Rev. Rhum. Engl. Ed. 64 12 (1997) 816-824
    • (1997) Rev. Rhum. Engl. Ed. , vol.64 , Issue.12 , pp. 816-824
    • Hayem, G.1
  • 40
    • 0030045912 scopus 로고    scopus 로고
    • Paraneoplastic rheumatic syndromes
    • Fortin P. Paraneoplastic rheumatic syndromes. Curr. Opin. Rheumatol. 8 1 (1996) 30-33
    • (1996) Curr. Opin. Rheumatol. , vol.8 , Issue.1 , pp. 30-33
    • Fortin, P.1
  • 41
    • 0034534016 scopus 로고    scopus 로고
    • Temporal concurrence of vasculitis and cancer: a report of 12 cases
    • Hutson T., and Hoffman G. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis. Care. Res. 13 6 (2000) 417-423
    • (2000) Arthritis. Care. Res. , vol.13 , Issue.6 , pp. 417-423
    • Hutson, T.1    Hoffman, G.2
  • 42
    • 0343953394 scopus 로고    scopus 로고
    • Cutaneous vasculitis and cancer: a clinical approach
    • González-Gay M., et al. Cutaneous vasculitis and cancer: a clinical approach. Clin. Exp. Rheumatol. 18 3 (2000) 305-307
    • (2000) Clin. Exp. Rheumatol. , vol.18 , Issue.3 , pp. 305-307
    • González-Gay, M.1
  • 43
    • 0037380435 scopus 로고    scopus 로고
    • The spectrum of cutaneous disease in multiple myeloma
    • Bayer-Garner I., and Smoller B. The spectrum of cutaneous disease in multiple myeloma. J. Am. Acad. Dermatol. 48 4 (2003) 497-507
    • (2003) J. Am. Acad. Dermatol. , vol.48 , Issue.4 , pp. 497-507
    • Bayer-Garner, I.1    Smoller, B.2
  • 44
    • 0022725087 scopus 로고
    • Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders
    • Longley S., Caldwell J., and Panush R. Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders. Am. J. Med. 80 (1986) 1027-1031
    • (1986) Am. J. Med. , vol.80 , pp. 1027-1031
    • Longley, S.1    Caldwell, J.2    Panush, R.3
  • 45
    • 0030988771 scopus 로고    scopus 로고
    • Mucocutaneous paraneoplastic syndromes
    • Cohen P., and Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin. Oncol. 24 3 (1997) 334-359
    • (1997) Semin. Oncol. , vol.24 , Issue.3 , pp. 334-359
    • Cohen, P.1    Kurzrock, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.